Business Wire

Denodo Integrates NVIDIA NIM Inference Microservices to Accelerate and Optimize AI Capabilities for Enterprises

2.6.2024 15:30:00 EEST | Business Wire | Press release

Share

Denodo, a leader in data management, announced that it has integrated NVIDIA NIM inference microservices into the Denodo Platform, as part of its focus on bolstering its rapidly expanding artificial intelligence (AI) capabilities.

The Denodo Platform's logical data management capabilities, combined with NVIDIA NIM, enable enterprise customers to:

  • Rapidly curate and transform data into AI-ready pipelines to feed large language models (LLMs)
  • Improve model accuracy and combat hallucinations by accessing trusted enterprise data through retrieval augmented generation (RAG) pipelines.
  • Simplify secure, real-time access to distributed enterprise knowledge for generative AI applications
  • Maintain data privacy/security and enforce granular access controls for AI models that access organizational data
  • Fast-track AI/ML deployments from data prep to model scoring with NVIDIA NeMo, leveraging an integrated data fabric for enterprise data input into this process

NVIDIA NIM is a collection of cloud-native microservices that simplify and accelerate the deployment of generative AI models across a variety of environments, including the cloud, on-premises data centers, and workstations. It connects the power of the latest foundational AI models, securely deployed on NVIDIA’s accelerated infrastructure, with enterprise customers everywhere.

The Denodo Platform’s integration of NVIDIA NIM helps customers seamlessly leverage advanced AI capabilities within their data management workflows. It also helps enable enterprises to deploy and scale generative AI applications with unprecedented speed and efficiency. Key use cases include improved analytics and robust AI-driven insights across such verticals as financial services, healthcare, retail, and manufacturing, accelerating time to insight from diverse data sources. As an NVIDIA Metropolis partner, Denodo is working to deploy vision AI and vision language model (VLM) NIM microservices to streamline industrial processes and increase worker safety.

Using the Denodo Platform with NVIDIA NeMo can significantly boost SQL query generation accuracy for LLMs. RAG capabilities enable more trustworthy responses by enabling models to retrieve relevant knowledge from the data fabric before generating output, and the Denodo Platform helps to simplify and accelerate data access, while reducing errors, when models query the platform.

By integrating NVIDIA NIM, Denodo helps ensure that customers will be able to maintain full control over their AI deployments, whether on premises or in the cloud. The integration is set to deliver significant business benefits, including accelerated time to value and enhanced security for AI applications.

“I am thrilled by this integration, and I think it's a sign of the direction in which Denodo's logical data management capabilities can take us,” said Narayan Sundar, Senior Director-Strategic Alliances at Denodo. “Denodo is at the forefront of supporting RAG-enabled GenAI applications with real-time, governed, trusted data from an organization’s vast data estates, and I look forward to seeing the innovations, as they start to emerge, from enterprise customers that leverage the Denodo Platform with NVIDIA NIM integration.”

Learn more about the Denodo Platform with NVIDIA NIM integration.

About Denodo

Denodo is a leader in data management. The award-winning Denodo Platform is the leading logical data management platform for delivering data in the language of business, at the speed of business, for all data-related initiatives across the organization. Realizing more than 400% ROI and millions of dollars in benefits, Denodo’s customers across enterprises in 30+ industries all over the world have received payback in less than six months. For more information, visit denodo.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
pr@denodo.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Dubai Culture Opens Registration for ISEA2026 Dubai26.10.2026 14:09:00 EET | Press release

Dubai Culture and Arts Authority (Dubai Culture) has opened registration for the 31st International Symposium on Electronic/Emerging Art (ISEA2026 Dubai), taking place from 6 to 15 November 2026 under the theme ‘ELYAH: Constellating Place, Data and Identity’. The symposium will be the largest edition to date, bringing together artists, researchers, and innovators from around the world to explore the intersection of art, science, and technology and exchange perspectives on the future of contemporary creative practice. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261026652826/en/ Dubai Culture Opens Registration for ISEA2026 Dubai (Graphic: AETOSWire) The event supports Dubai Culture’s efforts to advance the digital arts ecosystem, deliver on its Digital Arts Roadmap objectives, and empower local talent. It also reinforces Dubai’s position as a global cultural reference, a leader in innovation, a driver of the creative econo

Agendia Unveils Clinical Validation of AI-Driven Digital Pathology Approach26.10.2026 14:00:00 EET | Press release

Agendia, Inc., a leader in precision oncology for breast cancer, recently presented research introducing its investigational artificial intelligence (AI)-driven digital pathology approach for the MammaPrint®70-gene recurrence signature at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid. The podium presentation, delivered by co-founder and Chief Research Officer, Laura van ’t Veer, Ph.D., detailed the development and clinical validation of a deep learning pipeline that can infer MammaPrint (MP) risk categories directly from hematoxylin and eosin (H&E)-stained, whole-slide images (WSIs). The company also presented two additional posters highlighting data from the prospective, real-world FLEX Study (NCT03053193). “AI has been part of Agendia’s scientific foundation from the beginning and this study represents its continued evolution,” said Dr. Laura van ‘t Veer. "For the first time, we are presenting our work exploring whether the biological information represente

C.H. Robinson Debuts Lean AI for Ocean Shipping, Air Freight and Customs26.10.2026 14:00:00 EET | Press release

As the global leader in Lean AI, C.H. Robinson has launched new AI agents that perform work in ocean shipping, air freight and customs brokerage. They represent an expansion of the company’s Lean AI capabilities into freight forwarding, for the benefit of more customers, and into work so complex that a single shipping task can require over a dozen AI agents working in tandem. Continuing to disrupt itself and the industry, the company’s new tech brings substantial speed-to-market gains, precision and agility to customers’ supply chains without sacrificing human oversight or personal attention. The new tech includes: Price-quoting for ocean and air cargo: AI has determined and delivered over 80,000 price quotes for over 3,600 customers. Quotes that used to take a day for an air shipment and two to three days for an ocean shipment now take two to three minutes. Ocean booking: AI has begun to manage the thousands of booking requests C.H. Robinson receives every week. Customs: AI helps with

TVS Motor Company Returns to EICMA With New Models for Europe26.10.2026 13:45:00 EET | Press release

TVS Motor Company (TVSM), a global leader in two- and three-wheeler manufacturing, returns to EICMA in Milan this November, one year after its debut at the world’s largest two-wheeler exhibition. The company will present new models for Europe at a press conference on Tuesday, 3 November at 10:00 CET. The TVS stand is in Hall 18, Stand I64. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261026990290/en/ TVS Motor Company will present new models for Europe at a press conference on Tuesday, 3 November at 10:00 CET at EICMA this year. EICMA 2025 marked the beginning of TVS Motor's European growth journey. Since then, the company has focused on establishing the foundations for long-term success, building its dealer network, aftersales capabilities and customer support infrastructure across key markets. In Italy, its first European market, TVS now works with around 100 dealers. Retail sales in Italy are up 110% this year to Septem

Two-Year Data of Pimicotinib Demonstrated Durable Tumor Control and Sustained Improvement in TGCT Symptoms and Joint Function26.10.2026 13:00:00 EET | Press release

Merck, a leading science and technology company, today announced new two-year follow-up results from the Phase 3 MANEUVER study evaluating pimicotinib in patients with tenosynovial giant cell tumor (TGCT). The study showed that among patients initially randomized to pimicotinib, improvements in symptoms and joint function were observed as early as Week 5, sustained through two years, and continued to improve over time. Tumor responses remained robust1 and durable,2 and the safety profile was consistent with previous analyses. The findings are being presented today in the Sarcoma poster session at the European Society for Medical Oncology (ESMO) Congress 2026 (Presentation # 3747P). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022786567/en/ David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck "For people living with TGCT, the impact of the disease is often felt through persis

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye